Researchers Propose Solutions to Improve GLP-1 RA Access
Physician's Weekly
JUNE 18, 2025
Cost-sharing and education may improve access to GLP-1 therapies for obesity, but systemic barriers remain, requiring broader policy and clinical reforms. Waldrop, MD , and colleagues identified barriers to obesity medications more broadly—and potential solutions. They published their insights in Nature Medicine.
52 
Let's personalize your content